Group published“RIG-I-inducing Small Molecules Potently Inhibit HMA-resistant AML through Igniting the Overloaded dsRNA Arsenal”on《Advanced Science》
Xiao Shujun Awarded 2025 Postdoctoral Innovative Talent Support Program
The research group published in Fundamental Research in 2025, titled ‘p53 mutation associated diagnosis across cancer types, underlying hematological malignancy as an applicable cancer type to p53 rescue therapy’
